Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.

George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR.

Am J Psychiatry. 2000 Nov;157(11):1835-42.

PMID:
11058482
2.

Varying nicotine patch dose and type of smoking cessation counseling.

Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan IT, Hays JT, Lewis SF, Baker TB.

JAMA. 1995 Nov 1;274(17):1347-52.

PMID:
7563558
3.

The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.

Chou KR, Chen R, Lee JF, Ku CH, Lu RB.

Int J Nurs Stud. 2004 Mar;41(3):321-30.

PMID:
14967189
4.
5.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
6.

Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.

Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, Lauger GG, Marŭsić Z, Neese LW, Lundberg TG.

JAMA. 1994 Feb 23;271(8):595-600.

PMID:
8301791
7.

Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.

Dalack GW, Becks L, Hill E, Pomerleau OF, Meador-Woodruff JH.

Neuropsychopharmacology. 1999 Aug;21(2):195-202.

8.

A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.

Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, Jansons S, Wilhelm K.

Am J Psychiatry. 2006 Nov;163(11):1934-42.

PMID:
17074945
9.

The transdermal nicotine patch: results of a randomised placebo-controlled trial.

Richmond RL, Harris K, de Almeida Neto A.

Med J Aust. 1994 Jul 18;161(2):130-5.

PMID:
8028537
10.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
11.

Nicotine replacement therapy for smoking cessation.

Silagy C, Mant D, Fowler G, Lancaster T.

Cochrane Database Syst Rev. 2000;(3):CD000146. Review. Update in: Cochrane Database Syst Rev. 2001;(3):CD000146.

PMID:
10908462
12.

A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients.

Chen HK, Lan TH, Wu BJ.

Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):75-82. doi: 10.1007/s00406-012-0338-3. Epub 2012 Jun 23.

PMID:
22729212
13.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007253. doi: 10.1002/14651858.CD007253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD007253.

PMID:
20556777
14.

Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.

Selby P, Andriash K, Zawertailo L, Persad D, Zack M, Busto UE.

J Clin Psychopharmacol. 2013 Oct;33(5):667-74. doi: 10.1097/JCP.0b013e31829a829d.

PMID:
23963055
15.

Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation.

Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A.

Arch Fam Med. 1998 Nov-Dec;7(6):569-74.

PMID:
9821833
16.

Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.

Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB.

Chest. 1994 Feb;105(2):524-33.

PMID:
8306757
18.

A placebo controlled trial of bupropion for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR.

Biol Psychiatry. 2002 Jul 1;52(1):53-61.

PMID:
12079730
19.

[Tobacco and schizophrenia: therapeutic aspects].

Dervaux A, Laqueille X.

Encephale. 2007 Sep;33(4 Pt 1):629-32. Review. French.

PMID:
18033154
20.

Supplemental Content

Support Center